What Makes Cooper Companies (COO) an Investment Choice?

robot
Abstract generation in progress

The Cooper Companies (COO) was initiated as a pick by The London Company Mid Cap Strategy in its Q4 2025 investor letter. COO operates in medical devices through CooperVision (contact lenses) and CooperSurgical (women’s healthcare). Despite current margin challenges and recent stock weakness, the company is seen as attractive due to strong market share, high customer switching costs, and potential for margin expansion and operational improvements driven by activist involvement.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments